AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 126 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,385,373 | -39.4% | 1,157,582 | +5.4% | 0.00% | 0.0% |
| Q2 2023 | $12,183,418 | -36.6% | 1,098,595 | -12.3% | 0.00% | -50.0% |
| Q1 2023 | $19,225,292 | -15.5% | 1,252,462 | +22.2% | 0.00% | -33.3% |
| Q4 2022 | $22,741,465 | +1629.4% | 1,024,852 | +1171.8% | 0.00% | – |
| Q3 2022 | $1,315,000 | -32.6% | 80,580 | -40.0% | 0.00% | – |
| Q2 2022 | $1,951,000 | -3.5% | 134,229 | +22.7% | 0.00% | – |
| Q1 2022 | $2,021,000 | +13.7% | 109,372 | +46.2% | 0.00% | – |
| Q4 2021 | $1,778,000 | -41.2% | 74,817 | -39.1% | 0.00% | – |
| Q3 2021 | $3,026,000 | +19.8% | 122,837 | +20.2% | 0.00% | – |
| Q2 2021 | $2,525,000 | -26.0% | 102,183 | -34.7% | 0.00% | -100.0% |
| Q1 2021 | $3,413,000 | +99.0% | 156,540 | +132.9% | 0.00% | – |
| Q4 2020 | $1,715,000 | +1107.7% | 67,223 | +1232.5% | 0.00% | – |
| Q3 2020 | $142,000 | – | 5,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |